2′,3′-Didehydro-2′,3′-dideoxythymidine (D4T),an anti-HIV Agent

August E.M. Marongiu M.E. Lin T.-S. , and Prusoff W.H. (1988) Initial studies on the cellular pharmacology of 3′-deoxythymidin-2′-ene (d4T): a potent and selective inhibitor of human immunodeficiency virus. Biochem Pharmacol 37: 4419–4422.

Baba M. Pauwels R. Herdewijn P. De Clercq E. Desmyter J. , and Vandeputte M. (1987) Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus in vitro. Biochem Biophys Res Commun 142: 128–134.

Balzarini J. Kang G.J. Dalai M. Herdewijn P. De Clercq E. Broder S. , and Johns D.G. (1987) The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2′,3′-didehydro-2′,3′-dideoxyribonucleosides: a comparison with their parental 2,′,3′-dideoxyribonucleosides. Mol Pharmacol 32: 162–167.

Balzarini J. Pauwels R. Baba M. Herdewijn P. De Clercq E. Broder S. , and Johns D.G. (1988) The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol 37: 897–903.

Balzarini J. Herdewijn P. , and De Clercq E. (1989a) Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem 262: 6127–6133.

Balzarini J. van Aerschot A. Herdewijn P. , and De Clercq E. (1989b) 5-Chloro-substituted derivatives of 2′,3′-didehydro-2′,3′-dideoxyuridine, 5′-fluoro-2′,3′-dideoxyuridine and 3′-azido-2′,3′-dideoxyuridine as anti-HIV agents. Biochem Pharmacol 38: 869–874.

Chen C.-H. , and Cheng Y.-C. (1989) Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine. J Biol Chem 264: 11934–11937.

Chu C.K. Schinazi R.F. Ahn M.K. Ullas G.V. , and Gu Z.P. (1989) Structure–activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells. J Med Chem 32: 612–617.

Collins J.M. , and Unadkat J.D. (1989) Clinical pharmacokinetics of zidovudine. An overview of current data. Clin Pharmacokinet 17: 1–9.

Dunkle L. Cross A. Gugliotti R. Martin R. Browne M. , and Murray H. (1990) Dose-escalating study of safety and efficacy of dideoxy-didehydrothymidine (d4T) for HIV infection. Abstract no. 145. Antiviral Res Suppl. 1: 116.

Dyatkina N. Minassian S. Kukhanova M. Krayevsky A. von Janta-Lipinsky M. Chidgeavadze Z. , and Beabealashvilli R. (1987) Properties of 2′,3′-dideoxy-2′,3′-dehydrothymidine, 5′-triphosphate in terminating DNA synthesis catalyzed by several different DNA polymerases. FEBS Lett 219: 151–155.

Elwell L.P. Ferone R. Freeman G.A. Fyfe J.A. Hill J.A. Ray P.H. Richards C.A. Singer S.C. Knick V.B. Rideout J.L. , and Zimmerman T.P. (1987) Antibacterial activity and mechanism of action of 3′-azido-3′-deoxythymidine (BW A509U). Antimicrob Agents Chemother 31: 274–280.

Frick L.W. Nelson D.J. St Clair M.H. Furman P.A. , and Krenitsky T.A. (1988) Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154: 124–129.

Furman P.A. Fyfe J.A. St Clair M.H. Weinhold K. Rideout J.L. Freeman G.A. Lehrman S.N. Bolognesi D.P. Broder S. Mitsuya H. , and Barry D.W. (1986) Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333–8337.

Ghazzouli I. Hitchcock M. Brankovan V. Desiderio J. Sommadossi J.-P. August M. Lin T.-S. Prusoff W. Mansuri M. , and Martin J. (1988) 2′,3′-Dideoxy-2′,3′-didehydrothymidine (D4T): a potent and selective agent against human immunodeficiency virus (HIV). Antiviral Res 9: 119.

Gogu S.R. Beckman B.S. , and Agrawal K.C. (1989) Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells. Life Sci 45: iii–vii.

Hamamoto Y. Nakashima H. Matsui T. Matsuda A. Ueda T. , and Yamamoto N. (1987) Inhibitory effect of 2′,3′-didehydro-2′,3′-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus. Antimicrob Agents Chemother 31: 907–910.

Herdewijn P. Balzarini J. De Clercq E. Pauwels R. Baba M. Broder S. , and Vanderhaeghe H. (1987) 3′-substituted 2′,3′-dideoxynucleoside analogues as potential anti-HIV (HTLV-I/LAV) agents. J Med Chem 30: 1270–1278.

Ho H.-T. , and Hitchcock M.J.M. (1989a) Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob Agents Chemother 33: 844–849.

Ho H.-T. , and Hitchcock M.J.M. (1989b) Comparative cellular pharmacology of anti-HIV agents, 2′,3′-dideoxy-2′,3′-didehydrothymidine (D4T) and 3′-azido-2′,3′-dideoxythymidine in different cells. Program Abstr. 29th Intersci. Conf. Antimicrob Agents Chemother, abstr. no. 498.

Horwitz J.P. Chua J. da Rooge M.A. Noel M. , and Klundt I.L. (1966) Nucleosides. IX. The formation of 2′,3′-unsaturated pyrimidine nucleosides via a novel β-elimination reaction. J Org Chem 31: 205–211.

Inoue T. Tsushita K. Itoh T. Ogura M. Hotta T. Saneyoshi M. Yoshida S. Saitoh H. Tomoda Y. , and Nagai Y. (1989) In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus. Antimicrob Agents Chemother 33: 576–579.

Kaul S. Dandekar K.A. , and Pittman K.A. (1989) Analytical method for the quantification of 2′,3′-didehydro-3′-deoxythymidine, a new anti-human immunodeficiency virus (HIV) agent, by high-performance liquid chromatography (HPLC) and ultraviolet (UV) detection in rat and monkey plasma. Pharmacol Res 6: 895–899.

Kawaguchi T. Fukushima S. Ohmura M. Mishima M. , and Nakano M. (1980) Enzymatic and chemical stability of 2′,3′-dideoxy-2′,3′-didehydropyrimidine nucleosides: potential anti-acquired immunodeficiency syndrome agents. Chem Pharm Bull 37: 1944–1945.

Larder B.A. Darby G. , and Richman D.D. (1989) HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243: 1731–1734.

Larder B.A. Chesebro B. , and Richman D.D. (1990) Susceptibility of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob Agents Chemother 34: 436–441.

Lin T.-S. Chen M.S. McLaren C. Gao Y.-S. Ghazzouli I. , and Prusoff W.H. (1987a) Synthesis and antiviral activity of various 3′-azido, 3′-amino, 2′,3′-unsaturated, and 2′,3′-dideoxy analogues of pyrimidine deoxyribonucleosides against retroviruses. J Med Chem 30: 440–444.

Lin T.-S. Schinazi R.F. , and Prusoff W.H. (1987b) Potent and selective in vitro activity of 3′-deoxythymidin-2′-ene (3′-deoxy-2′,3′-didehydrothymidine) against human immunodeficiency virus. Biochem Pharmacol 36: 2713–2718.

Mansuri M.M. Starrett J.E. Ghazzouli I. Hitchcock M.J.M. Sterzycki R.Z. Brankovan V. Lin T.-S. August E.M. Prusoff W.H. Sommadossi J.-P. , and Martin J.C. (1989) 1-(2,3-Dideoxy-β-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selectively anti-HIV agent. J Med Chem 32: 461–466.

Mansuri M.M. Hitchcock M.J.M. Buroker R.A. Bregman C.L. Ghazzouli I. Desiderio J.V. Starrett J.E. Sterzycki R.Z. , and Martin J.C. (1990) Comparison of biological properties in vitro and toxicity in vivo of three thymidine analogues (D4T, FddT and AZT) active against HIV. Antimicrob Agents Chemother 34: 637–641.

Marongiu M.E. August E.M. , and Prusoff W.H. (1990) Effect of 3′-deoxythymidin-2′-ene (d4T) on nucleoside metabolism in H9 cells. Biochem Pharmacol 39: 1523–1528.

Martin J.C. Hitchcock M.J.M. Fridland A. Ghazzouli I. Kaul S. Dunkle L.M. Sterzycki R.Z. , and Mansuri M.M. (1990) Comparative studies of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) with other pyrimidine nucleoside analogues. Annals NY Acad Sci 616: 22–28.

Matthes E. Lehmann C. Scholtz D. von Janta-Lipinsky M. Gaertner K. Rosenthal H.A. , and Langen P. (1987) Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases α and β. Biochem Biophys Res Commun 148: 78–85.

North T.W. Cronn R.C. Remington K.M. , and Tandberg R.T. (1990) Direct comparisons of inhibitor sensitivities of reverse transcriptase from feline and human immunodeficiency viruses. Antimicrob Agents Chemother 34: 1505–1507.

Ono K. Nakane H. Herdewijn P. Balzarini J. , and De Clercq E. (1989) Differential inhibitory effects of several pyrimidine 2′,3′-dideoxynucleoside 5′-triphosphates on the activities of reverse transcriptase and various cellular DNA polymerases. Mol Pharmacol 35: 578–583.

Perno C.F. Yarchoan R. Cooney D.A. Hartman N.R. Webb D.S.A. Hao Z. Mitsuya H. Johns D.G. , and Broder S. (1989) Replication of human immunodeficiency virus in monocytes: granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′,3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 169: 933–951.

Russell J.W. Whiterock V.J. Marrero D. , and Klunk L.J. (1990) Disposition in animals of a new anti-HIV agent: 2′,3′-didehydro-3′-deoxythymidine. Drug Metab Disp 18: 153–157.

Schinazi R.F. Boudinot F.D. Doshi K.J. , and McClure H.M. (1990) Pharmacokinetics of 3′-fluoro-3′-deoxythymidine and 3′-deoxy-2′,3′-didehydrothymidine in rhesus monkeys. Antimicrob Agents Chemother 34: 1214–1219.

Schreiber S.L. , and Ikemoto N. (1988) Synthesis of chemically reactive analogues of AZT and their biological evaluation against HIV. Tetrahedron Lett 29: 3211–3214.

Simpson M.V. Chin C.D. Keilbaugh S.A. Lin T.-S. , and Prusoff W.H. (1989) Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs whiGh inhibit HIV-1 replication. Biochem Pharmacol 38: 1033–1036.

Sommadossi J.-P. Zhu Z. Carlisle R. Xie M.-Y. Weidner D.A. , and el Kouni M.H. (1990) Novel pharmacological approaches to the treatment of AIDS and potential use of uridine phosphorylase inhibitors. In: Advances in Chemotherapy of AIDS (eds Diasio R.B. , and Sommadossi J.-P. ), pp. 63–73. Pergamon Press Inc., New York.

Starnes M.C. , and Cheng Y.-C. (1987) Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus. J Biol Chem 262: 988–991.

St Clair M.H. Richards C.A. Spector T. Weinhold K.J. Miller W.H. Langlois A.J. , and Furman P.A. (1987) 3′-Azido-3′-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother 31: 1972–1977.

Tochikura T.S. Nakashima H. , and Yamamoto N. (1989) Antiviral agents with activity against human retroviruses. J Acquir Immune Def Syndr 2: 441–447.

Yokota T. Mochizuki S. Konno K. Mori S. Shigeta S. , and De Clercq E. (1991) Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis. Antimicrob Agents Chemother 35: 394–397.

Zhu Z. Ho H.-T. Hitchcock M.J. , and Sommadosi J.-P. (1990) Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in peripheral blood mononuclear cells. Biochem Pharmacol 39: R15–R19.